5.11.4. Societal impact
Public sympathy and charity for people with skin disease
is limited. This is surprising considering skin disease is so common and that
it can affect people in so many ways. Scleroderma, both systemic and localised,
directly restricts mobility and functioning of the limbs, while leg ulcers
produce chronic pain and limit the ability to walk. Some inflammatory skin
diseases such as occupational hand dermatitis or hand psoriasis confer a direct
disability by affecting one’s ability to use his/her hands. Atopic eczema and
scabies are intensely itchy disorders, leading to loss of sleep for those who
suffer from it and for their families. Moreover, on the next day they also
cause lack of concentration due to drowsiness.
Chronic suffering rather than mortality is characteristic
for most skin diseases. Nevertheless, there are exceptions, e.g. once melanoma
has spread beyond the regional lymph nodes or into the bloodstream, the outlook
is very poor. Melanoma kills a disproportionate number of young economically
active people when compared to other cancers (melanoma comprises 1-2% of all
cancer-related fatalities). Several other less common skin cancers such as Merkel
cell tumours, malignant fibrous histiocytomas, mycosis fungoides, other
lymphomas, angiosarcomas and Kaposi sarcoma are similarly aggressive or
particularly difficult to treat. A wide range of multisystem dermatological
diseases are associated with reduced life expectancy: collagen vascular
diseases, acquired blistering diseases and genetic diseases such as xeroderma
pigmentosum, epidermolysis bullosa and many others. Rare skin diseases such as
blistering drug reactions can result in a person losing almost their entire
skin - as in a severe burn. In the absence of a correctly functioning skin,
temperature regulation, salt and water balance and defense against infections
are largely impaired.
These types of skin conditions are associated to a
mortality of around 30%.
In addition to physical symptoms, perhaps the most
significant way in which skin disease affects people is the effect it has on
personal psychological well-being (Ryan, 1991). Disfiguring skin disease on
visible sites such as the face (e.g. acne) can result in loss of self-esteem,
depression and poorer job prospects. Indeed, the quality of life scores for
people with skin disease are often worse than those of people with more
traditional “medical” disorders such as angina and hypertension.
Although skin disease is rarely life threatening, the
moderate morbidity and its high prevalence place skin disease among the top
four chronic diseases when entire communities are considered. Various studies
have assessed the economic impact of specific skin diseases and these have
shown that direct costs are as high as for many other diseases, with much of
that cost being borne by patients as well as society. Small changes in the way
this balance functions can have a profound effect on a country’s health care
budget because skin disease affects so many people (Verboom et al, 2002;
Williams, 1997). Other costs such as unemployment and losing an economically
viable sector of the country’s workforce are also important. Indirect costs
e.g. the adverse effects on the quality of life and the opportunity costs due
to time lost for daily topical therapy and skin care in many skin diseases also
need to be considered within the framework of economic evaluations.